Dual antiretroviral therapy for HIV infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual antiretroviral therapy for HIV infection

Published:2017-07-11 Issue:8 Volume:16 Page:923-932
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Soriano Vicente¹,Fernandez-Montero Jose Vicente²,Benitez-Gutierrez Laura³,Mendoza Carmen de³,Arias Ana³,Barreiro Pablo¹,Peña José M.¹,Labarga Pablo⁴

Affiliation:

1. Infectious Diseases Unit, La Paz University Hospital & Autonomous University, Madrid, Spain

2. Department of Infectious Diseases, University Hospital Crosshouse, Kilmarnock, Scotland, UK

3. Internal Medicine Department, Puerta de Hierro Research Institute, Majadahonda, Spain

4. Internal Medicine Department, Nuestra Señora de la Paz Hospital, Madrid, Spain

Funder

Ministerio de Economía y Competitividad (MINECO, FEDER

Fundación MEDINA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2017.1343300

Reference72 articles.

1. Life expectancy in HIV-positive persons in Switzerland

2. Antiretroviral drug-related toxicities – clinical spectrum, prevention, and management

3. Dual antiretroviral therapy: finding a place in the battle

4. Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere?

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy;Antioxidants;2024-04-26

2. What´s new in Infectology?;Vnitřní lékařství;2024-04-10

3. Integrase;Metalloenzymes;2024

4. Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-11-01

5. A Computational Approach for Exploring Indinavir as a Potent Protease Inhibitor and Development of Its Microsphere for Anticancer Activity;Journal of Pharmaceutical Innovation;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3